Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.71% | 26.78% | 16.94% | 32.06% | 35.28% |
| Total Depreciation and Amortization | 18.83% | 20.25% | 25.55% | 9.25% | 6.23% |
| Total Amortization of Deferred Charges | -52.53% | -52.53% | -76.06% | 12.22% | 12.22% |
| Total Other Non-Cash Items | 242.21% | 208.43% | 182.36% | -384.46% | 50.39% |
| Change in Net Operating Assets | -53.53% | 0.34% | 4.95% | 85.17% | -0.64% |
| Cash from Operations | 24.09% | 35.56% | 23.06% | 35.69% | 34.10% |
| Capital Expenditure | 5.75% | 14.20% | -23.55% | 4.51% | -15.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 103.43% | 101.57% | -488.69% | -1,302.47% | -144.27% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.96% | 79.89% | 108.88% | -93.17% | -102.70% |
| Cash from Investing | 81.34% | 77.24% | -83.33% | -192.80% | -91.37% |
| Total Debt Issued | -51.68% | -113.79% | 525.35% | 36.44% | -4.44% |
| Total Debt Repaid | -118.72% | -20.44% | -10.14% | 38.47% | 44.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,171.15% | -1,171.01% | -1,171.01% | -20.48% | -20.48% |
| Cash from Financing | -298.71% | -279.57% | 114.07% | 175.96% | 2,420.21% |
| Foreign Exchange rate Adjustments | 348.45% | 119.45% | -1,721.03% | -44.15% | 45.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 184.44% | 354.56% | 439.58% | 204.95% | 68.21% |